Bacil Pharma Limited (BOM:524516)

Bacil Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	314	685	610	86	32	34
Market Cap Growth	-41.86%	12.33%	607.73%	166.97%	-4.36%	83.65%
Enterprise Value	308	669	610	83	28	33
Last Close Price	21.85	47.73	42.49	14.63	5.48	5.73
PE Ratio	19.68	44.04	150.92	-	-	-
PB Ratio	1.26	2.76	2.40	7.10	2.94	2.76
P/TBV Ratio	1.26	2.76	2.40	7.10	2.94	2.76
P/FCF Ratio	44.07	96.27	152.16	-	-	-
P/OCF Ratio	44.07	96.27	152.16	-	-	-
EV/FCF Ratio	43.27	94.03	152.28	-	-	-
Debt / Equity Ratio	-	-	0.01	0.08	0.02	0.03
Debt / FCF Ratio	-	-	0.41	-	-	-
Net Debt / Equity Ratio	-0.02	-0.02	-0.11	0.05	-0.18	-0.22
Net Debt / EBITDA Ratio	2.33	2.33	10.67	-0.30	1.12	1.76
Net Debt / FCF Ratio	-0.80	-0.80	-6.72	-19.64	1.35	0.07
Quick Ratio	0.68	0.68	16.92	0.37	7.87	6.49
Current Ratio	0.68	0.68	17.21	0.46	8.19	6.69
Return on Equity (ROE)	6.19%	6.19%	3.03%	-5.11%	-8.77%	-295.12%
Return on Assets (ROA)	-0.58%	-0.58%	-1.18%	-9.62%	-9.37%	-3.70%
Return on Invested Capital (ROIC)	-1.00%	-1.04%	-2.09%	-17.40%	-19.41%	-13.92%
Return on Capital Employed (ROCE)	-1.00%	-1.00%	-1.00%	-15.60%	-16.30%	-13.00%
Earnings Yield	4.96%	2.27%	0.66%	-0.69%	-3.16%	-114.37%
FCF Yield	2.27%	1.04%	0.66%	-0.03%	-4.57%	-118.79%
Buyback Yield / Dilution	-121.94%	-121.94%	-6.92%	1.47%	-1.71%	-0.99%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error